ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Recurrence"

  • 2016 American Transplant Congress

    Factors Associated with Response to Plasmapheresis in Patients with Recurrent FSGS.

    J. Shoji,1 V. Tatapudi,2 Z. Laszik,1 A. Jones,3 J. Wolf,4 D. Adey,1 F. Vincenti.1

    1Department of Medicine, Division of Nephrology, University of California-San Francisco, California, CA; 2Department of Medicine, Division of Nephrology, New York University, New York, NY; 3Department of Sociology, George Washington University, Washington, DC; 4Transplant Surgery, Piedmont Transplant Institute, Atlanta, GA.

    Background:Idiopathic focal segmental glomerulosclerosis (FSGS) is one of the primary glomerular diseases that commonly recurs in renal allograft and is known to be associated with…
  • 2016 American Transplant Congress

    Treatment of Post-Transplant Focal Glomerulosclerosis: The Effect on Histopathology Lesions and Podocyte Foot Process Effacement.

    K. Koutroutsos,1 J. Moss,2 L. Moran,2 T. Cook,2 R. Charif,1 D. Taube,1 C. Roufosse,2 M. Loucaidou.1

    1Renal and Transplant Centre, Imperial Healthcare NHS Trust, London, United Kingdom; 2Department of Histopathology, Imperial Healthcare NHS Trust, London, United Kingdom.

    Background: Post-transplant Focal Segmental Glomerulosclerosis (FSGS) is associated with increased risk for renal allograft failure. It has been reported in the literature that podocyte foot…
  • 2016 American Transplant Congress

    An Economical and Effective Vaccination Program in Patients Transplanted for Hepatitis B Virus Related Liver Diseases: A Prospective Study.

    W. Ju, A. Yang, Q. Ren, D. Wang, Z. Guo, Y. Ma, A. Hu, Q. Tai, X. Zhu, X. He.

    Organ Transplantation Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

    Aims: To prospectively investigate the efficacy and safety of procedural HBV vaccination in patients transplanted for HBV related liver diseases for prevention of hepatitis B…
  • 2016 American Transplant Congress

    Outcomes of Ribavirin Free Treatment of Recurrent Genotype 1 , Hepatitis C Infection Post Liver Transplant.

    D. Jones,1 S. Baggett,1 M. Shoreibah,2 O. Massoud.2

    1Department of Pharmacy, UAB Hospital, Birmingham, AL; 2Department of Gastroenterology, UAB Hospital, Birmingham, AL.

    Background. With the development of direct-acting antivirals, the treatment of Hepatitis C Virus (HCV) has become a rapidly changing area of medical practice. Data on…
  • 2016 American Transplant Congress

    Insights into the Treatment of Post-Transplant Focal Glomerulosclerosis: Experience Gained from a Concise Diagnostic and Management Protocol.

    K. Koutroutsos,1 R. Charif,1 L. Moran,2 J. Moss,2 T. Cook,2 C. Roufosse,2 D. Taube,1 M. Loucaidou.1

    1Kidney and Transplant Centre, Imperial Healthcare NHS Trust, London, United Kingdom; 2Department of Histopathology, Imperial Healthcare NHS Trust, London, United Kingdom.

    Background: Recurrence of Focal Glomerulosclerosis (FSGS) after kidney transplantation is associated with poor graft survival. We present results from a concise diagnostic and management protocol…
  • 2016 American Transplant Congress

    Virological Response at 4 Weeks With a Sofosbuvir-Based Antiviral Regimen in Liver Transplant Recipients with Recurrent Hepatitis C.

    T. Pastrana-Camacho,1 M. Bradley,1 H. Winters,1 S. Black,2 K. Porter,3 K. Mumtaz.4

    1Pharmacy, The Ohio State University-Wexner Medical Center, Columbus, OH; 2Department of Surgery, The Ohio State University-Wexner Medical Center, Columbus, OH; 3Center for Biostatistics, The Ohio State University-Wexner Medical Center, Columbus, OH; 4Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, The Ohio State University-Wexner Medical Center, Columbus, OH.

    Background: The literature is growing in the area of safety, efficacy and tolerability of sofosbuvir (SOF)- based antivirals therapy (AVT) in recurrent hepatitis C virus…
  • 2016 American Transplant Congress

    Recurrence of FSGS Post Kidney Transplantation: Salvage Therapy with ACTHAR® Gel.

    P. Vaitla, D. Daswatta, A. Guasch.

    Transplant, Emory University, Atlanta, GA.

    Recurrence of FSGS post kidney transplantation: Salvage therapy with ACTHAR® gel.Introduction:Recurrence of FSGS post kidney transplantation may reach 25-50%. Failure of treatment or incomplete remission…
  • 2016 American Transplant Congress

    Lower Renal Graft Function and Accelerated Fibrosis in HIV-Infected Transplant Recipients with Previous HIVAN Compared to Non HIVAN HIV-Positive Transplant Recipients.

    M.-N. Peraldi,1 H. Ayari,1 M. Burbach,1 C. Randoux,2 E. Pillebout,1 N. De Castro,3 J.-M. Molina,3 D. Glotz.1

    1Nephrologie et Transplantation, Hôpital Saint-Louis et Université Paris-Diderot, Paris, France; 2Néphrologie, Hôpital Bichat et Université Paris-Diderot, Paris, France; 3Service de Maladies Infectieuses, Hôpital Saint-Louis et Université Paris-Diderot, Paris, France.

    Several studies reported reduced renal allograft survival rates among HIV-infected transplant recipients. Few data focus on histological lesions and their progression in renal grafts from…
  • 2016 American Transplant Congress

    Use of Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma Does Not Increase Recurrence.

    A. Gupta, M. Ramsay, G. Saracino, T. Anthony, R. Goldstein, G. McKenna, N. Onaca, R. Ruiz, G. Klintmalm, P. Kim.

    Baylor University Medical Center, Dallas, TX.

    IntroductionAutotransfusion (AT) is rarely used in liver transplantation of hepatocellular carcinoma (HCC) patients due to the fear of disease transmission. Leukocyte depleting filters (LDF) can…
  • 2016 American Transplant Congress

    Occult Multifocal Hepatocellular Carcinoma in Surgical Patients.

    D. Aufhauser Jr,1 E. Sadot,2 D. Murken,1 K. Eddinger,1 D. Goldberg,3 E. Furth,4 P. Abt,1 R. DeMatteo,2 M. Levine.1

    1Surgery, University of Pennsylvania, Philadelphia, PA; 2Surgery, Memorial Sloan Kettering Cancer Center, New York, NY; 3Medicine, University of Pennsylvania, Philadelphia, PA; 4Pathology, University of Pennsylvania, Philadelphia, PA.

    Introduction: Resection of hepatocellular carcinoma (HCC) is associated with high rates of intrahepatic recurrence. However, it is unclear whether recurrence results from occult multifocal disease…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences